CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Metastatic Castration-Resistant Prostate Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!
<< View More Conferences
2018 State of the Science Summit on Genitourinary Cancers
Oncology Conference Multimedia
View more videos >>
Dr. Balar Discusses the Impact of Immunotherapy on Bladder Cancer
Dr. Wise Discusses Challenges With Immunotherapy in Prostate Cancer
Dr. Wysock on the Role of Cytoreductive Nephrectomy in RCC
Oncology Conference Articles
Cytoreductive Nephrectomy Retains Role in Modern RCC Era
James Wysock, MD, discusses the evolution of cytoreductive nephrectomy in renal cell carcinoma.
Robotic Approaches Advancing Surgical Scope in Muscle-Invasive Bladder Cancer
William C. Huang, MD, discusses the transition from open cystectomy to minimally invasive robotic-assisted surgery in the management of muscle-invasive bladder cancer.
Balar Addresses Advances in Bladder and Kidney Cancer
Arjun V. Balar, MD, discusses the landscape of current and future standards of care for immunotherapy in bladder and kidney cancer.
Expert Highlights Significance of MRI-Guided Prostate Biopsies
Samir Taneja, MD, discusses his research on MRI-guided prostate biopsies and other modalities in development.
Expert Shares Insight on Immunotherapy, Emerging Strategies in Prostate Cancer
David R. Wise, MD, PhD, discusses the promise for immunotherapy and other emerging approaches in the field of prostate cancer.
Screening Continues to Evolve in Prostate Cancer
Marc A. Bjurlin, DO, discusses ongoing efforts to optimize prostate cancer screening.
Burden of Cardiovascular Disease in Prostate Cancer
The Role of Patient Education in Side Effect Management
FDA Approves New Abiraterone Acetate Formulation for mCRPC
New Strategies Aim at Survival Protein MCL-1
Frontline Ibrutinib Plus Obinutuzumab Improves PFS in Phase III CLL Trial
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.